Shandong Sito Bio-technology Co., Ltd. (SZSE: 300583)
Health Care · Pharmaceuticals · CN
CN¥12.89
+0.08% today · -28.7% 1Y
Shandong Sito Bio-technology Co., Ltd. (SZSE: 300583) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $363.75M and employs 990 people.
Over the last twelve months the share price has lost 28.7%, trading between 10.63 and 18.35.
Tweenvest scores Shandong Sito Bio-technology Co., Ltd. across four factors: quality 56/100, value 58/100, growth 3/100, dividend 2/100. Its strongest factor is value.
300583 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $363.75M
- Revenue (TTM)
- $157.32M
- P/E
- —
- EPS
- -0.22
- Dividend yield
- 0.12%
- Beta (5Y)
- 0.11
- 52-week high
- CN¥18.35
- 52-week low
- CN¥10.63
- Avg volume (3M)
- —
- Shares outstanding
- 189.70M
- Employees
- 990
- Next earnings
- —
About Shandong Sito Bio-technology Co., Ltd.
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. Shandong Sito Bio-technology Co., Ltd. was founded in 2002 and is based in Heze, China.
- ISIN
- CNE100002F36
- Founded
- 2002
- Listed since
- Jan 9, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $153.38 | +0.54% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.13 | +0.21% |
Figures last refreshed Aug 18, 2026.